Global Personalized Medicine Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 9371

Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
In 2018, the global Personalized Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Personalized Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicine development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Agilent Technologies
Amgen
Astellas Pharma
Astrazeneca
Bayer AG
Celgene Corporation
Glaxosmithkline Plc
Illumina
Johnson & Johnson
Laboratory Corporation
Merck
Novartis AG
Roche Holding AG
Siemens AG
Takeda Pharmaceutical Company Limited

Market segment by Type, the product can be split into
Personalized Medicine Diagnostics
Personalized Medical Care
Personalized Medicine Therapeutics
Personalized Nutrition and Wellness

Market segment by Application, split into
Oncology
Central Nervous System (CNS)
Immunology
Respiratory
Other Applications

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Personalized Medicine status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Personalized Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicine Market Size Growth Rate by Type (2014-2025)
1.4.2 Personalized Medicine Diagnostics
1.4.3 Personalized Medical Care
1.4.4 Personalized Medicine Therapeutics
1.4.5 Personalized Nutrition and Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicine Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Central Nervous System (CNS)
1.5.4 Immunology
1.5.5 Respiratory
1.5.6 Other Applications
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Personalized Medicine Market Size
2.2 Personalized Medicine Growth Trends by Regions
2.2.1 Personalized Medicine Market Size by Regions (2014-2025)
2.2.2 Personalized Medicine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Personalized Medicine Market Size by Manufacturers
3.1.1 Global Personalized Medicine Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalized Medicine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Personalized Medicine Key Players Head office and Area Served
3.3 Key Players Personalized Medicine Product/Solution/Service
3.4 Date of Enter into Personalized Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Personalized Medicine Market Size by Type (2014-2019)
4.2 Global Personalized Medicine Market Size by Application (2014-2019)

5 United States
5.1 United States Personalized Medicine Market Size (2014-2019)
5.2 Personalized Medicine Key Players in United States
5.3 United States Personalized Medicine Market Size by Type
5.4 United States Personalized Medicine Market Size by Application

6 Europe
6.1 Europe Personalized Medicine Market Size (2014-2019)
6.2 Personalized Medicine Key Players in Europe
6.3 Europe Personalized Medicine Market Size by Type
6.4 Europe Personalized Medicine Market Size by Application

7 China
7.1 China Personalized Medicine Market Size (2014-2019)
7.2 Personalized Medicine Key Players in China
7.3 China Personalized Medicine Market Size by Type
7.4 China Personalized Medicine Market Size by Application

8 Japan
8.1 Japan Personalized Medicine Market Size (2014-2019)
8.2 Personalized Medicine Key Players in Japan
8.3 Japan Personalized Medicine Market Size by Type
8.4 Japan Personalized Medicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Personalized Medicine Market Size (2014-2019)
9.2 Personalized Medicine Key Players in Southeast Asia
9.3 Southeast Asia Personalized Medicine Market Size by Type
9.4 Southeast Asia Personalized Medicine Market Size by Application

10 India
10.1 India Personalized Medicine Market Size (2014-2019)
10.2 Personalized Medicine Key Players in India
10.3 India Personalized Medicine Market Size by Type
10.4 India Personalized Medicine Market Size by Application

11 Central & South America
11.1 Central & South America Personalized Medicine Market Size (2014-2019)
11.2 Personalized Medicine Key Players in Central & South America
11.3 Central & South America Personalized Medicine Market Size by Type
11.4 Central & South America Personalized Medicine Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalized Medicine Introduction
12.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Agilent Technologies
12.2.1 Agilent Technologies Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalized Medicine Introduction
12.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2014-2019)
12.2.5 Agilent Technologies Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalized Medicine Introduction
12.3.4 Amgen Revenue in Personalized Medicine Business (2014-2019)
12.3.5 Amgen Recent Development
12.4 Astellas Pharma
12.4.1 Astellas Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalized Medicine Introduction
12.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2014-2019)
12.4.5 Astellas Pharma Recent Development
12.5 Astrazeneca
12.5.1 Astrazeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalized Medicine Introduction
12.5.4 Astrazeneca Revenue in Personalized Medicine Business (2014-2019)
12.5.5 Astrazeneca Recent Development
12.6 Bayer AG
12.6.1 Bayer AG Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalized Medicine Introduction
12.6.4 Bayer AG Revenue in Personalized Medicine Business (2014-2019)
12.6.5 Bayer AG Recent Development
12.7 Celgene Corporation
12.7.1 Celgene Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalized Medicine Introduction
12.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2014-2019)
12.7.5 Celgene Corporation Recent Development
12.8 Glaxosmithkline Plc
12.8.1 Glaxosmithkline Plc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalized Medicine Introduction
12.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2014-2019)
12.8.5 Glaxosmithkline Plc Recent Development
12.9 Illumina
12.9.1 Illumina Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalized Medicine Introduction
12.9.4 Illumina Revenue in Personalized Medicine Business (2014-2019)
12.9.5 Illumina Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalized Medicine Introduction
12.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2014-2019)
12.10.5 Johnson & Johnson Recent Development
12.11 Laboratory Corporation
12.12 Merck
12.13 Novartis AG
12.14 Roche Holding AG
12.15 Siemens AG
12.16 Takeda Pharmaceutical Company Limited

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details